Conventional mental health therapies have offered little help. But a growing number of professional athletes are finding the path back to a better life with a more unconventional therapy—psychedelics. These five athletes are leading the way in psychedelic therapy.
No fewer than 50 companies have shown interest in offering psychedelic therapy to their employees through healthcare plan startup Enthea.
The largest Phase 3 clinical trial investigating the efficacy and tolerability of psilocybin for treatment-resistant depression (TRD) has finally begun.
Ketamine has a history as a date rape drug. As it becomes a therapy for depression, can it shake its bad rap?
Psychedelic art has been around for thousands of years across…
“Australian native ‘magic mushrooms’ may have evolved different methods for psilocybin production and offer adaptations that are preferential for use in clinical treatments,” explains University of Queensland mycologist Dr. Alistair McTaggart.
Defiance has launched the world’s second psychedelics-focused ETF as investing in psychedelic therapy and treatment accelerates.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.
